|
Volumn 286, Issue 52, 2011, Pages 44350-44356
|
Molecular basis of maillard amide-advanced glycation end product (AGE) formation in vivo
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADVANCED GLYCATION END PRODUCTS;
END-PRODUCTS;
ENZYMATIC PROCESS;
FORMATION PATHWAYS;
FREE AMINO ACIDS;
GLUCOSONE;
GLYCATION;
HEALTHY SUBJECTS;
HUMAN PLASMAS;
IN-VITRO;
IN-VIVO;
MAILLARD;
MAILLARD REACTION;
MODEL EXPERIMENTS;
MODEL REACTIONS;
MOLECULAR BASIS;
NON-ENZYMATIC;
PHYSIOLOGICAL CONDITION;
UREMIC PATIENTS;
AMIDES;
DIALYSIS;
GLUCOSE;
GLYCOSYLATION;
PHYSIOLOGICAL MODELS;
AMINO ACIDS;
ADVANCED GLYCATION END PRODUCT;
N6 ACETYL LYSINE;
N6 FORMYL LYSINE;
N6 GLYCERINYL LYSINE;
N6 LACTOYL LYSINE;
UNCLASSIFIED DRUG;
ACYLATION;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
ENZYME DEGRADATION;
ENZYME MECHANISM;
GLYCATION;
HEMODIALYSIS PATIENT;
HUMAN;
HUMAN CELL;
IN VIVO STUDY;
MOLECULAR MECHANICS;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTEIN FUNCTION;
UREMIA;
AGED;
AGED, 80 AND OVER;
AMIDES;
FEMALE;
GLUCOSE;
GLYCOSYLATION END PRODUCTS, ADVANCED;
HUMANS;
LYSINE;
MAILLARD REACTION;
MALE;
MIDDLE AGED;
RENAL DIALYSIS;
UREMIA;
|
EID: 84455172979
PISSN: 00219258
EISSN: 1083351X
Source Type: Journal
DOI: 10.1074/jbc.M111.282442 Document Type: Article |
Times cited : (47)
|
References (32)
|